Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Clinical trial NCT03122106 · TERMINATED
Trial details
- NCT number
- NCT03122106
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-05
- Primary completion
- 2021-09-03
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.